Skip to main content

Month: June 2020

Ehitusleping Leedus (tuulepargi taristurajatiste ehitus Telšiais)

ASi Merko Ehitus kontserni kuuluv UAB Merko Statyba ning E energija gruppi kuuluv UAB L-Vėjas sõlmisid 15. juunil 2020 lepingu tuulepargi taristurajatiste ehitustöödeks Telšiai rajoonis Leedus. Tööd hõlmavad tuulikute aluste ja teede rajamist ning tuulikute elektrifitseerimist.   Lepingu maksumus on üle 13 miljoni euro, millele lisandub käibemaks. Tööde valmimise tähtaeg on 2021. aasta detsembris.  UAB Merko Statyba (merko.lt) on Leedu ehitusettevõte, mis teostab üld- ja elamuehituse töid.  Lisainfo: UAB Merko Statyba ehitusdirektor Jaanus Rästas, tel: +370 6875 0680.    Priit RoosimägiFinantsüksuse juhtAS Merko EhitusTelefon:  +372 650 1250E-post: priit.roosimagi@merko.ee  AS Merko Ehitus (group.merko.ee) kontserni kuuluvad Eestis AS Merko Ehitus Eesti, Lätis SIA Merks, Leedus UAB Merko Statyba ning Norras Peritus Entreprenør AS. Peatöövõtjana...

Continue reading

AppTech Corp. Announces 2020 Annual Shareholder Meeting

CARLSBAD, Calif., June 15, 2020 (GLOBE NEWSWIRE) — As a newly registered and reporting company with the SEC, AppTech Corp. (OTC PINK: APCX) announced today it filed its proxy statement and will hold its Annual Shareholder Meeting on Tuesday, July 28, 2020. The company is excited at the opportunity to expand its Board of Directors with experienced leaders at the meeting. To protect the safety of shareholders during COVID-19, and enable them to attend despite their location, AppTech will hold the meeting exclusively online. Meeting details and instructions to access proxy materials have been disseminated to shareholders of record via direct mail. Only such shareholders are entitled to notice of the Annual Meeting or any adjournment thereof. If you are a shareholder and do not receive notice by June 24, 2020, please contact AppTech...

Continue reading

Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19

SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today a license  to commercialize Tempol, a novel patented investigational drug for the treatment of Coronavirus (COVID-19).  The license includes the worldwide use of Tempol for the treatment of all respiratory diseases including asthma, respiratory syncytial virus, influenza and COVID-19.  In addition, the exclusive license includes the use of Tempol for reducing radiation dermatitis in patients undergoing treatment for cancer.  A phase 2 radiation dermatitis clinical study has already been successfully completed, as well as discussions with FDA regarding the design of a pivotal phase 3 study. The license was obtained from Matrix Biomed. In consideration for Matrix providing the exclusive rights under its patent rights...

Continue reading

ADM Endeavors, Inc. (ADMQ) Engages Architectural Firm to Plan New 70,000 Square Foot Facility

DALLAS, TX, June 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce that an architecture firm has been chosen to develop the site planning and design for a 70,000 sq. ft. warehouse building with retail space in Fort Worth, Texas which will facilitate the planned expansion of Just Right Products, Inc., a wholly owned subsidiary of ADM Endeavors, Inc.ADM Endeavors, Inc. CEO Marc Johnson explains that the architecture firm of John W. Hover Architect, Roanoke, Texas, will be developing the site planning and design for the warehouse building with retail spaces.  Just Right Products anticipates occupying it in the first quarter of 2021.The Company is currently located in Haltom City and operates in a space of 18,000 square feet. This expansion will allow Just Right Products to continue...

Continue reading

Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation

FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) —  via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms. Patricia Whelan. “The management team at BioElectronics thanks Patricia Whelan for her service and appreciates her willingness to stay on until a qualified replacement accepted a board position following the death of Andrew Whelan, the founder of BioElectronics Corporation,” said Keith Nalepka, Vice President of Sales. “We are pleased to welcome Dr. Staelin as an independent director and Chairman to BioElectronics Corporation’s board. Dr. Staelin rejoins BioElectronics at an exciting time as we continue to drive our...

Continue reading

Polydex Pharmaceuticals Issues First Quarter Financial Results

TORONTO, June 15, 2020 (GLOBE NEWSWIRE) — Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the first quarter of fiscal 2021, the period ending April 30, 2020.  All figures are reported in U.S. dollars.Management considers the quarter’s results satisfactory under the circumstances of the Covid Pandemic which hit Europe in Q1. This affected European and Asian orders as the global economy slowed significantly.In April we implemented our pandemic plan and closed the plant for two weeks. During this time we developed reduced hours or working from home programs and increased sanitation plans for the facility. We restarted mid-month and our programs appear to be working well. Raw Materials have become a concern with some instability of delivery. We are in regular communication...

Continue reading

Rogers family donates $60 million to help most vulnerable Canadians dealing with the economic fallout from the COVID-19 pandemic

The Rogers family marks the 60th anniversary of Rogers Communications with $60 million in community investments in support of Canadian families in needTORONTO, June 15, 2020 (GLOBE NEWSWIRE) — A healthy meal, a safe place to call home, and opportunities for kids to grow and learn – these most basic needs are out of reach for too many Canadians, especially now. In response to this urgent need, and as Rogers Communications celebrates its 60th anniversary serving Canadians, the Rogers family today announced a $60-million community donation to various charities across Canada to help Canadians most affected by the financial impact that has followed the COVID-19 health crisis.“Our family is honoured to be able to do a small part to help Canadians and Canadian families as they try to recover from the difficult financial challenges that COVID-19...

Continue reading

Don de 60 millions de dollars de la famille Rogers pour venir en aide aux Canadiens les plus vulnérables touchés par les répercussions économiques de la pandémie de COVID-19

La famille Rogers souligne le 60e anniversaire de Rogers Communications par des investissements communautaires de 60 millions de dollars pour aider les familles canadiennes dans le besoinTORONTO, 15 juin 2020 (GLOBE NEWSWIRE) — Un repas nourrissant, un chez-soi sécuritaire et des occasions pour les enfants de s’épanouir et d’apprendre : ces besoins fondamentaux sont hors de portée pour un trop grand nombre de Canadiens, surtout en ce moment. En réponse à ce besoin urgent en cette année où Rogers Communications célèbre son 60e anniversaire au service des Canadiens, la famille Rogers a annoncé aujourd’hui un don communautaire de 60 millions de dollars à divers organismes caritatifs partout au pays afin d’aider les Canadiens les plus touchés par les répercussions financières découlant de la crise de la COVID-19.« Notre famille est honorée...

Continue reading

Medtronic Micra™ AV Receives CE Mark

World’s Smallest Pacemaker Can Now Treat Patients with AV Block, Allowing More Potential Candidates for Leadless PacingDUBLIN, June 15, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for Micra™ AV Transcatheter Pacing System (TPS), the world’s smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical signals between the chambers of the heart (the atria and the ventricle) are impaired. Medtronic now offers the first and only CE Mark approved leadless pacemaker portfolio, expanding the number of potential candidates for this groundbreaking technology throughout the world. First implants of Micra AV recently occurred in Spain by Dr. José Ramón González Juanatey at the...

Continue reading

FAX Capital Announces 2020 Annual General and Special Meeting to be Held Virtually

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICESTORONTO, June 15, 2020 (GLOBE NEWSWIRE) — FAX Capital Corp. (the Company) (TSX: FXC & FXC.WT) announced today that it will host its annual general and special meeting of shareholders (the AGM) on a virtual electronic basis only.  The AGM will be held at the originally scheduled date and time of June 25, 2020 at 2:00 p.m. (Toronto time).Due to the impact of the COVID-19 pandemic and in response to the continued public health measures enacted by the federal and provincial governments, the decision has been made to move the AGM to a virtual-only setting. This decision was made after considering provincial and federal guidance and regulations regarding public gatherings and to proactively protect the health and well-being of the Company’s stakeholders,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.